These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18285359)

  • 21. Comparison of off-pump coronary artery bypass grafting with percutaneous coronary intervention versus drug-eluting stents for three-vessel coronary artery disease.
    Yi G; Youn YN; Yoo KJ; Hong YS
    Ann Thorac Surg; 2008 Nov; 86(5):1438-43. PubMed ID: 19049727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors affecting post minimally invasive direct coronary artery bypass grafting incidence of myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting and mortality of cardiac origin.
    Kofidis T; Gerd Paeschke H; Lichtenberg A; Emmert M; Woitek F; Didilis V; Haverich A; Klima U
    Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):49-53. PubMed ID: 18786942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Revascularization of unprotected left main coronary artery disease with percutaneous coronary intervention: the role of drug-eluting stents.
    Kirtane AJ; Chieffo A; Magni V; Mehran R; Colombo A; Moses JW
    Minerva Cardioangiol; 2008 Feb; 56(1):43-53. PubMed ID: 18432168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pericardial patch on coronary aneurysm.
    Nakamura T
    Ann Thorac Surg; 2009 Jan; 87(1):351; author reply 351-2. PubMed ID: 19101341
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug-eluting stents vs. coronary-artery bypass grafting.
    Burack JH
    N Engl J Med; 2008 Jun; 358(24):2643; author reply 2643-4. PubMed ID: 18557176
    [No Abstract]   [Full Text] [Related]  

  • 26. Towards defining the role of drug eluting stents.
    Tarantini G; Ramondo A; Razzolini R
    Minerva Cardioangiol; 2008 Feb; 56(1):29-34. PubMed ID: 18432166
    [No Abstract]   [Full Text] [Related]  

  • 27. Detrimental effects of coronary stenting on subsequent coronary artery bypass surgery: is there another flag on the field?
    Lazar HL
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):276-7. PubMed ID: 19619765
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug-eluting stents vs. coronary-artery bypass grafting.
    Abbate A; Lipinski MJ
    N Engl J Med; 2008 Jun; 358(24):2642; author reply 2643-4. PubMed ID: 18557173
    [No Abstract]   [Full Text] [Related]  

  • 29. Multivessel PCI versus CABG: one-year outcomes and cost analysis.
    Choudary J; Arif I; Helmy T
    J Invasive Cardiol; 2007 Nov; 19(11):476-7. PubMed ID: 17986723
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of coronary artery disease: coronary by-pass or balloon dilatation?].
    Heikkilä J; Järvinen A
    Duodecim; 2000; 116(19):2087-96. PubMed ID: 12017729
    [No Abstract]   [Full Text] [Related]  

  • 31. [Coronary angioplasty and coronary surgery: the socioeconomic considerations].
    Lázaro y de Mercado P
    Rev Esp Cardiol; 1993; 46 Suppl 3():1-14. PubMed ID: 8303047
    [No Abstract]   [Full Text] [Related]  

  • 32. Safety and effectiveness of drug-eluting stents among diabetic patients: a propensity analysis.
    Ko DT; Chiu M; Austin PC; Bowen J; Cohen EA; Tu JV
    Am Heart J; 2008 Jul; 156(1):125-34. PubMed ID: 18585507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving long-term outcomes following coronary artery bypass graft or percutaneous coronary revascularisation: results from a large, population-based cohort with first intervention 1995-2004.
    Blackledge HM; Squire IB
    Heart; 2009 Feb; 95(4):304-11. PubMed ID: 19001000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CABG versus DES PCI in diabetics with multivessel disease: back to the BARI registry.
    Hillegass W
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):59-60. PubMed ID: 19089939
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease.
    Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Choo SJ; Song H; Chung CH; Lee JW; Park SW; Park SJ
    Circulation; 2008 Apr; 117(16):2079-86. PubMed ID: 18413495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meditations on secondary revascularisation in the aftermath of the SYNTAX trial.
    Garg S; Serruys PW
    EuroIntervention; 2009 May; 5 Suppl D():D14-20. PubMed ID: 19736064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment and care of coronary artery syndrome in Finland].
    Vikman S; Airaksinen J; Tierala I; Peuhkurinen K; Majamaa-Voltti K; Niemelä M; Tuunanen H; Niemelä K; Nieminen MS
    Duodecim; 2005; 121(7):753-9. PubMed ID: 15909962
    [No Abstract]   [Full Text] [Related]  

  • 39. Evolution of interventions for complex coronary lesions.
    Sachdeva R; Prayaga S; Bansal D; Bagwe S; Hughes B; Molavi B; Romeo F; Mehta JL
    Minerva Cardioangiol; 2009 Feb; 57(1):57-75. PubMed ID: 19202519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical results of unprotected left main coronary stenting.
    Ben-Dor I; Vaknin-Assa H; Lev E; Brosh D; Fuchs S; Assali A; Kornowski R
    Isr Med Assoc J; 2009 Mar; 11(3):154-9. PubMed ID: 19544705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.